Distal pancreatectomy (DP) with or without splenectomy is commonly indicated for pancreatic body or tail lesions. Postoperative pancreatic fistula (POPF) remains the commonest complication after DP. A pre-operatively placed pancreatic stent across papilla can decrease the pressure gradient between pancreatic duct and duodenum. Therefore, the pancreatic juice flow is redirected from the pancreatic transection plane and leakage from pancreatic stump is much reduced. This study aims to evaluate whether pre-operatively placed pancreatic stent can prevent POPF by a randomized controlled trial.
A randomised-controlled trial is performed to evaluate the efficacy of preoperative pancreatic duct stenting in preventing post-operative pancreatic fistula after distal pancreatectomy with or without splenectomy. Patients will be randomised to pre-operative stent group or surgery alone group. Pre-operative pancreatic duct stenting will be performed 1-2 weeks before surgery. The stent will be removed 4 weeks after operation. The post-operative pancreatic fistula rate, morbidity, mortality and total length of stay were compared between the 2 groups.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
56
Pancreatic stent of appropriate size and length is inserted to the pancreatic duct before distal pancreatectomy
No preoperative stenting with distal pancreatectomy alone
Prince of Wales Hospital
Hong Kong, Hong Kong
RECRUITINGNumber of participants with postoperative pancreatic fistula
The number of participants developing post-operative pancreatic fistula, which is defined as drain fluid amylase more than 3 times the upper limit of the normal value of serum amylase on or after postoperative day 3
Time frame: Day 3 after operation
Number of participants developing post-operative morbidity
Post-operative complications, graded according to the Clavien-Dindo classification, are recorded
Time frame: 90 days
Number of participants developing post-operative mortality
All cause mortality after operation was recorded
Time frame: 90 days
Total length of hospital stay of participants
The total number of days spent in hospital calculated from the day of admission to discharge for every participant, including the time spent for pre-operative endoscopy and operation
Time frame: 90 days after endoscopy and operation
Number of participants developing complications related to Endoscopic Retrograde Cholangiography
All complications occurred after Endoscopic Retrograde Cholangiopancreatography were recorded
Time frame: 14 days after endoscopy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.